Search Results 1141-1150 of 18319 for Hepatitis b

1. Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation - Mayo Clinic

   - Known active infection with hepatitis B virus or hepatitis C virus - Known infection with human immunodeficiency virus (HIV) - Use of any other ...

2. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

   Part B: To ... Patient is known to be human immunodeficiency virus (HIV) positive, Hepatitis B surface antigen-positive or active hepatitis C infection.

3. Tests and Procedures - Mayo Clinic

   Narrow your search ; active Find a procedure that begins with the letter A A ; Find a procedure that begins with the letter B · B ; Find a procedure that begins ...

4. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   Evidence of active hepatitis B (HBV) or hepatitis C (HCV) infection. Other known active malignancy < 5 years prior to registration. EXCEPTIONS: Non ...

5. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

   NOTE: Testing for HIV, hepatitis B or hepatitis C is not required unless clinically indicated. Patients with a history of hepatitis C virus (HCV) infection ...

6. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

   ... B) in patients with CLL/SLL who have been previously treated with at least ... * Active hepatitis B or hepatitis C * Known active cytomegalovirus (CMV) ...

7. Mayo Clinic Transplant Center - Doctors

   B · Find ... Vijayan Balan, M.D.. Gastroenterologist; Hepatologist. Phoenix, AZ. Areas of focus: Hepatitis C ...

8. Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary - Mayo Clinic

   Known prior/current history of hepatitis related to hepatitis B or hepatitis C. Uncontrolled intercurrent illness including, but not limited to the following ...

9. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   The atezolizumab plus interferon alfa-2b arm (Arm B), plus pegylated ... Participants with active hepatitis B; Participants with active hepatitis C ...

10. Genotype Optimal Regimens 1 GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ES

    GLE/PIB 8 wks a-TE with PEG/RBV, no cirrhosis 8 wks b-Cirrhosis and TE with non-NS5A DAA 12 wks c-ESRD 12 wks d-Post-LT without cirrhosis and KT 12 wks.